Citations

Showing 10 of 107969 citations.

Ballooned hepatocytes, undead cells, sonic hedgehog, and Vitamin E: Therapeutic implications for nonalcoholic steatohepatitis
Hirsova, Petra , Hirsova, Petra , Gores, Gregory J.

Mayo Clinic

Hepatology | June 26, 2014 | Volume: 61 | Issue: 1 | Pages: 15-17

10.1002/hep.27279 | PMID 24975580 Get It

Do cutaneous nerves cross the midline?
Capek, Stepan , Tubbs, R. Shane , Spinner, Robert J.

Mayo Clinic

Clinical Anatomy | June 26, 2014 | Volume: 28 | Issue: 1 | Pages: 96-100

10.1002/ca.22427 | PMID 24976246 Get It

Standard cutaneous innervation maps show strict midline demarcation. Although authors of these maps accept variability of peripheral nerve distribution or occasionally even the midline overlap of cutaneous nerves, this concept seems to be neglected by many other anatomists. To support the statement that such transmedian overlap exists, we performed an extensive literature search and found ample evidence for all regions (head/neck, thorax/abdomen, back, perineum, and genitalia) that peripheral nerves cross the midline or communicate across the midline. This concept has substantial clinical implications, most notably in anesthesia and perineural tumor spread. This article serves as a springboard for future anatomical, clinical, and experimental research. Clin. Anat. 28:96–100, 2015. © 2014 Wiley Periodicals, Inc.
Parenchymal cryobiopsies for interstitial lung diseases: A step forward in disease management
Maldonado, Fabien , Moua, Teng , Skalski, Joseph H.

Mayo Clinic

Respirology | June 26, 2014 | Volume: 19 | Issue: 6 | Pages: 773-774

10.1111/resp.12332 | PMID 24965516 Get It

See article, page 900
Fracture of the Cam Mechanism of a Posterior-Stabilized Total Knee Femoral Component: A Previously Unrecognized Mode of Failure
Stryker, Louis S., Lewallen, David G.

Mayo Clinic

JBJS Case Connector | June 26, 2014 | Volume: 4 | Issue: 2 | Pages: e51

10.2106/jbjs.cc.m.00129 | PMID 29252564 Get It

Use of a preclinical model of pancreas cancer to identify potential candidates for rapalogue therapy
Takeuchi, Kenneth K., Crawford, Howard C, Crawford, Howard C.

Mayo Clinic

Gut | June 26, 2014 | Volume: 63 | Issue: 9 | Pages: 1379-1380

10.1136/gutjnl-2014-307317 | PMID 24966285 Get It

Using Sit-Stand Workstations to Decrease Sedentary Time in Office Workers: A Randomized Crossover Trial
Dutta, Nirjhar , Koepp, Gabriel A., Stovitz, Steven D. , Levine, James A. , Pereira, Mark A. , Pereira, Mark A

Mayo Clinic

International Journal of Environmental Research and Public Health | June 26, 2014 | Volume: 11 | Issue: 7 | Pages: 6653-6665

10.3390/ijerph110706653 | PMID 24968210 Get It

Objective: This study was conducted to determine whether installation of sit-stand desks (SSDs) could lead to decreased sitting time during the workday among sedentary office workers. Methods: A randomized cross-over trial was conducted from January to April, 2012 at a business in Minneapolis. 28 (nine men, 26 full-time) sedentary office workers took part in a 4 week intervention period which included the use of SSDs to gradually replace 50% of sitting time with standing during the workday. Physical activity was the primary outcome. Mood, energy level, fatigue, appetite, dietary intake, and productivity were explored as secondary outcomes. Results: The intervention reduced sitting time at work by 21% (95% CI 18%–25%) and sedentary time by 4.8 min/work-hr (95% CI 4.1–5.4 min/work-hr). For a 40 h work-week, this translates into replacement of 8 h of sitting time with standing and sedentary time being reduced by 3.2 h. Activity level during non-work hours did not change. The intervention also increased overall sense of well-being, energy, decreased fatigue, had no impact on productivity, and reduced appetite and dietary intake. The workstations were popular with the participants. Conclusion: The SSD intervention was successful in increasing work-time activity level, without changing activity level during non-work hours.
Identification and lateral membrane localization of cyclin M3, likely to be involved in renal Mg2+handling in seawater fish
Islam, Zinia, Hayashi, Naoko, Inoue, Hana, Umezawa, Takahiro, Kimura, Yuuri, Doi, Hiroyuki , Romero, Michael F. , Hirose, Shigehisa , Kato, Akira , Inoue, Hana, Romero, Michael F , Kato, Akira

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | June 26, 2014 | Volume: 307 | Issue: 5 | Pages: R525-R537

10.1152/ajpregu.00032.2014 | PMID 24965791 Get It

The kidney of marine teleosts is the major site of Mg2+excretion and produces urine with a high Mg2+concentration. However, the transporters involved in Mg2+excretion are poorly understood. The cyclin M (Cnnm; also known as ancient conserved domain protein) family comprises membrane proteins homologous to the bacterial Mg2+and Co2+efflux protein, CorC. To understand the molecular mechanism of Mg2+homeostasis in marine teleosts, we analyzed the expression of the C nnm family genes in the seawater (SW) pufferfish, torafugu ( Takifugu rubripes), and the closely related euryhaline species, mefugu ( Takifugu obscurus). Database mining and phylogenetic analysis indicated that the Takifugu genome contains six members of the Cnnm family: two orthologs of Cnnm1, one of Cnnm2, one of Cnnm3, and two of Cnnm4. RT-PCR analyses indicated that Cnnm2, Cnnm3, and Cnnm4a are expressed in the kidney, whereas other members are mainly expressed in the brain. Renal expression of Cnnm3 was upregulated in SW mefugu, whereas renal expression of Cnnm2 was upregulated in freshwater (FW) mefugu. No significant difference was observed in renal expression of Cnnm4a between SW and FW mefugu. In situ hybridization and immunohistochemical analyses of the SW mefugu kidney revealed that Cnnm3 is expressed in the proximal tubule, and its product localizes to the lateral membrane. When Cnnm3 was expressed in Xenopus laevis oocytes, whole cellular Mg2+content and free intracellular Mg2+activity significantly decreased. These results suggest that Cnnm3 is involved in body fluid Mg2+homeostasis in marine teleosts.
Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population
Siontis, Konstantinos C. , Geske, Jeffrey B. , Ong, Kevin , Ommen, Steve R. , Nishimura, Rick A. , Gersh, Bernard J. , Geske, Jeffrey B

Mayo Clinic

Journal of the American Heart Association | June 26, 2014 | Volume: 3 | Issue: 3 | Pages: No page available

10.1161/jaha.114.001002 | PMID 24965028 Get It

Background Atrial fibrillation ( AF ) is a common sequela of hypertrophic cardiomyopathy ( HCM ), but evidence on its prevalence, risk factors, and effect on mortality is sparse. We sought to evaluate the prevalence of AF , identify clinical and echocardiographic correlates, and assess its effect on mortality in a large high‐risk HCM population. Methods and Results We identified HCM patients who underwent evaluation at our institution from 1975 to 2012. AF was defined by known history (either chronic or paroxysmal), electrocardiogram, or Holter monitoring at index visit. We examined clinical and echocardiographic variables in association with AF . The effect of AF on overall and cause‐specific mortality was evaluated with multivariate Cox proportional hazards models. Of 3673 patients with HCM , 650 (18%) had AF. Patients with AF were older and more symptomatic ( P <0.001). AF was less common among patients with obstructive HCM phenotype and was associated with larger left atria, higher E/e’ ratios, and worse cardiopulmonary exercise tolerance (all P values<0.001). During median (interquartile range) follow‐up of 4.1 (0.2 to 10) years, 1069 (29%) patients died. Patients with AF had worse survival compared to those without AF ( P <0.001). In multivariate analysis adjusted for established risk factors of mortality in HCM , the hazard ratio (95% confidence interval) for the effect of AF on overall mortality was 1.48 (1.27 to 1.71). AF did not have an effect on sudden or nonsudden cardiac death. Conclusions In this large referral HCM population, approximately 1 in 5 patients had AF . AF was a strong predictor of mortality, even after adjustment for established risk factors.
Reply
Khosroshahi, Arezou , Cheryk, Lynn A., Bloch, Donald B. , Stone, John H., Stone, John H.

Mayo Clinic

Arthritis & Rheumatology | June 25, 2014 | Volume: 66 | Issue: 11 | Pages: 3247-3248

10.1002/art.38751 | PMID 24965491 Get It